Department of Medicine, Shiga University of Medical Science, Seta, Otsu, Shiga, 520-2192, Japan.
Division of Blood Purification, Shiga University of Medical Science, Otsu, Shiga, Japan.
CEN Case Rep. 2020 Aug;9(3):266-270. doi: 10.1007/s13730-020-00468-8. Epub 2020 Apr 8.
A 43-year-old male patient on maintenance hemodialysis had an enhanced computed tomography scan examination with iohexol for the first time 10 min before regular hemodialysis therapy. At the start of hemodialysis, no symptoms were observed, and the platelet count was 148,000/μl. Approximately 1 h after starting hemodialysis, dyspnea and chest discomfort appeared. Since oxygen saturation of the peripheral artery decreased to 87%, oxygen administration was immediately started while continuing hemodialysis therapy. Furthermore, gingival hemorrhage was observed, and the platelet count decreased to 5000/μl. We were carefully monitoring his conditions while continuing hemodialysis and oxygen administration, but no further deterioration was observed. Thereafter, these symptoms and severe thrombocytopenia gradually improved without additional treatment. At the end of hemodialysis, these symptoms completely disappeared. As well, the platelet count recovered to 35,000/μl at the end of hemodialysis and increased to 92,000/μl the next morning. From the clinical course, we diagnosed with contrast medium-induced thrombocytopenia. Acute thrombocytopenia is a rare complication induced by the contrast medium. Until now, 16 cases on contrast medium-induced thrombocytopenia have been reported. Our case spontaneously recovered from severe thrombocytopenia relatively earlier than previous reports. Our patient started hemodialysis therapy 10 min after an enhanced computed tomography examination. Early removal of contrast medium by hemodialysis might be associated with early improvement. We should acknowledge that contrast media have potential to induce severe thrombocytopenia, even in patients on maintenance hemodialysis.
一位 43 岁男性维持性血液透析患者,在常规血液透析治疗前 10 分钟首次进行碘海醇增强 CT 扫描检查。开始血液透析时无任何症状,血小板计数为 148,000/μl。开始血液透析约 1 小时后,出现呼吸困难和胸部不适。由于外周动脉血氧饱和度下降至 87%,立即开始吸氧,同时继续血液透析治疗。此外,还观察到牙龈出血,血小板计数降至 5000/μl。我们在继续血液透析和吸氧的同时密切监测他的病情,但未观察到进一步恶化。此后,这些症状和严重血小板减少症逐渐改善,无需额外治疗。血液透析结束时,这些症状完全消失。同时,血小板计数在血液透析结束时恢复到 35,000/μl,第二天早上增加到 92,000/μl。从临床过程来看,我们诊断为造影剂诱导的血小板减少症。急性血小板减少症是造影剂引起的罕见并发症。到目前为止,已经报告了 16 例造影剂诱导的血小板减少症。我们的病例与之前的报告相比,严重血小板减少症的恢复相对较早。我们的患者在增强 CT 检查后 10 分钟开始血液透析治疗。早期通过血液透析清除造影剂可能与早期改善有关。我们应该认识到,即使是维持性血液透析患者,造影剂也有可能引起严重的血小板减少症。